Schering-Plough Corporation discovers, develops, manufactures, and sells pharmaceuticals worldwide. It operates in three segments: Human Prescription Pharmaceuticals, Animal Health, and Consumer Health Care. Human Prescription Pharmaceuticals segment offers human pharmaceutical products in six therapeutic areas, including cardiovascular, central nervous system, immunology and infectious disease, oncology, respiratory, and women’s health. This segment sells its products through sales representatives to hospitals, managed care organizations, wholesale distributors, and retail pharmacists. Animal Health segment discovers, develops, manufactures, and markets animal health products, including vaccines. Its products include livestock products, poultry products, companion animal products, and aquaculture products. This segment offers its products to veterinarians, distributors, and animal producers. Consumer Health Care segment manufactures and sells over-the-counter, foot care, and sun care products. This segment sells its products through wholesale and retail drug, food chain, and mass merchandiser outlets. The company has a joint venture with Merck & Co., Inc. for the development and management of two cholesterol-lowering drugs and an allergy/asthma drug. Schering-Plough Corporation was founded in 1928 and is headquartered in Kenilworth, New Jersey.